| EXICURE INC. DL-,0001 |
| USA |
| Gesundheit |
| US30205M3097 / A40L5C |
| 2H0 (Frankfurt) / XCUR (NASDAQ) |
| FRA:2H0, ETR:2H0, 2H0:GR, NASDAQ:XCUR |
| - |
| https://www.exicuretx.com.. |
|
Exicure, Inc. is an early-stage biotechnology company specializing in the development of nucleic acid therapies aimed at targeting ribonucleic acid (RNA) against validated biological targets. Founded in 2011 and headquartered in Chicago, Illinois, th..
>Volltext.. |
| 23.08 Mio. EUR |
| 20.04 Mio. EUR |
| - |
| -8.37 Mio. EUR |
| -4.28 Mio. EUR |
| -0.66 EUR |
| 0.15 Mio. EUR |
| 3.25 Mio. EUR |
| -7.41 Mio. EUR |
| 0.96 |
| -100% |
| 55.06% |
| - |
| - |
| - |
| - |
| EXICURE |
| 04.04.26 |
|